Medinice S.A.
ICE.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.30 | 3.81 |
| FCF Yield | -7.02% | -15.83% | -7.25% | -5.13% |
| EV / EBITDA | 1.15 | -11.18 | -14.31 | -34.09 |
| Quality | ||||
| ROIC | 44.10% | -15.83% | -12.83% | -7.24% |
| Gross Margin | -13.83% | 33.33% | 54.88% | 74.31% |
| Cash Conversion Ratio | -0.10 | 0.68 | 0.57 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.57% | -7.90% | -12.88% | 20.55% |
| Free Cash Flow Growth | 63.14% | -57.38% | -4.46% | 3.19% |
| Safety | ||||
| Net Debt / EBITDA | -0.23 | 2.08 | 4.44 | 12.29 |
| Interest Coverage | 716.04 | -93.21 | -83.32 | -81.40 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -312.22 | -884.11 | -1,693.47 | -212.13 |